Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.11, $0.03 better than the analyst estimate of $0.08. Revenue for the quarter came in at $21.5 million versus the consensus estimate of $20.05 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.